Shanghai's Viva extends HK biotech party in city's hottest 2019 IPO

Photo: Bloomberg

Viva Biotech Holdings bucked a decline across Asia on its trading debut following Hong Kong’s most popular initial public offering this year.

The Shanghai-based company lured retail investors with orders for about 107 times the shares initially available to them, the highest ratio among 2019 offerings above $100 million in the city, data compiled by Bloomberg show. The institutional tranche of the IPO was “significantly oversubscribed,” Viva said in a filing, without providing more details.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter